Fundraising FoxCRISPR Startups
4 companies tagged CRISPR, with their investors and founders.
Nephrogen develops AI-powered AAV delivery vehicles for genetic medicines targeting kidney and pancreatic diseases. The company uses high-throughput in vivo screening to design tissue-specific viral vectors that are significantly more efficient and less immunogenic than existing alternatives.
8 investors
Uncommon Therapeutics uses advanced technologies to develop drugs targeting rare genetic diseases, starting with Rett Syndrome, a neurodevelopmental disorder affecting approximately 1 in 10,000 girls. The company combines disease expertise with efficient drug development to advance therapeutics from discovery to clinical application.
7 investors
Algen Biotechnologies discovers and develops small molecule therapeutics for cancer and inflammatory diseases using CRISPR, RNAi, and machine learning to decode functional gene networks and predict drug responses.
5 investors
LEAH Labs develops CAR-T cell therapy for pets, starting with dogs with B cell lymphoma, using a virus-free gene editing platform to produce engineered cell therapy doses at low cost. It targets general practice veterinarians across the USA, with a longer-term goal of extending its therapies to humans.
3 investors